The Venture Codex Logo

The Venture Codex

Overview

Personalized phage therapy company for bacterial infections.

Total Raised

$13 M

Rounds

2

Links

Verticals

Biotechnology
Health Care
Medical Device

Investment History

  1. Debt Financing

    Apr 2021

    $2M

  2. Series B

    Jan 2018

    $11M

Team

Guy Charles Fanneau de La Horie

CEO

Thibaut du Fayet

Chief Operating Officer

Cindy Fevre

Directeur scientifique